Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma

Clinical Cancer Research

Volumn 8, Issue 3, 2002, Pages 782-787

  García Castellano, José M ^a   Villanueva, Alberto ^a   Healey, John H ^a   Sowers, Rebecca ^a   Cordon Cardo, Carlos ^a   Huvos, Andrew ^a   Bertino, Joseph R ^a   Meyers, Paul ^a   Gorlick, Richard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; GENOMIC DNA; MESSENGER RNA; PHOSPHORYLASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 9P; DNA DETERMINATION; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURINE SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; BONE NEOPLASMS; CELL CYCLE PROTEINS; CHILD; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; EXONS; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PURINE-NUCLEOSIDE PHOSPHORYLASE; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036305950     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Methylthioadenosine
2. Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme
3. INK4a, methylthioadenosine phosphorylase, and the α- and β-interferons in human pancreatic cell carcinoma cell lines and its implications for chemotherapy
4. Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells
5. 5′-Methylthioadenosine metabolism and methionine synthesis in mammalian cells grown in culture
6. Genomic cloning of methylthioadenosine phosphorylase: A purine metabolic enzyme deficient in multiple cancer
7. Deletion of p16 and p15 genes in brain tumor
8. Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma
9. Construction of a 2.8 megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21
10. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's Lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma
11. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro
12. INK4a gene in acute type adult T-cell leukemia
13. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer
14. INK4a (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC)
15. The 9p21 region in bladder cancer cell lines: Large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes
16. MTAP gene deletion in endometrial cancer
17. Chromosome aberrations in metastatic ovarian cancer: Relationship with abnormalities in primary tumors
18. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas
19. p16 deletion and mutation analysis in human brain tumors
20. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression
21. Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcoma
22. Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma
23. 1, and other 9p21 markers in human malignant cell lines
24. Inhibition of Ras-induced proliferation and cellular transformation by p16INK4
25. Alterations of the p15, p16, and p18 genes in osteosarcoma
26. CDK4 gene amplification in osteosarcoma: Reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons
27. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma
28. CDKN2A gene deletions and loss of p16 expression occur in osteosarcoma that lack RB alterations
29. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma
30. - malignant cells: Restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis
31. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: Strategies for enzyme-targeted therapy